PEN-866 in Patients With Advanced Solid Malignancies
Conditions: Carcinoma; Sarcoma; Rhabdomyosarcoma; Neoplasms; Small Cell Lung Cancer; Triple Negative Breast Cancer; Adenocarcinoma of the Pancreas; Colorectal Carcinoma; Gastric Adenocarcinoma; Advanced Cancer; Solid Tumor; Solid Carcinoma Intervention: Drug: PEN-866 Sponsor: Tarveda Therapeutics Recruiting - verified July 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Gastroenterology | Pancreas | Pancreatic Cancer | Research | Rhabdomyosarcoma | Sarcomas